INSIGHTS ON CLINICAL TRIAL DESIGN
-
![GettyImages-1137736725 data platform]( "Achieving A 2.67x Reduction In Study Build Time For An Innovative Neuromodulation Study")
Achieving A 2.67x Reduction In Study Build Time For An Innovative Neuromodulation StudyThis study explores the potential of Focused Ultrasound Neuromodulation in deepening meditative states, and the platform that helps enhance the overall experience for researchers and participants alike.
-
![Reducing The Travel Burden For Patients]( "Reducing The Travel Burden For Patients - The Benefits Of Mobile Vision Clinics")
Reducing The Travel Burden For Patients - The Benefits Of Mobile Vision ClinicsTravel to trial sites can be a major hurdle for patients considering participation, but mobile vision clinics are providing a solution to improve accessibility, capacity, and patient enrollment.
-
![GettyImages-1197955157-finances-money-financial-valuation]( "Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study")
Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 StudyExplore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
-
![GettyImages-2203372173-assay-wells-elisa]( "Choosing The Most Effective Method For Biopharmaceutical Development")
Choosing The Most Effective Method For Biopharmaceutical DevelopmentExplore how the application of protein assays extend from basic research to the development of cutting-edge therapies, which makes them indispensable in the quest to improve human health.
-
Sol-Gel Builds Awareness Of Rare Skin Condition, Generates Leads4/1/2026
Explore a 60-day HCP Awareness email campaign that surpassed industry benchmarks and generated a substantial number of leads.
-
Demonstrating IDS Value With Time-Based Metrics6/10/2026
Explore how leading IDS pharmacies are using remote monitoring workflows and digital accountability systems to improve accuracy, reduce site burden, and maintain audit readiness.
-
Virtual eConsent For Decentralized Trials12/23/2025
Virtual eConsent improves accessibility and compliance in decentralized trials, streamlining enrollment with a secure, user-friendly process for informed consent in remote research.
-
Human Abuse Potential: Study Management5/1/2026
Strengthen your human abuse potential studies through thoughtful, targeted volunteer selection, with clearly defined inclusion and exclusion criteria, and disciplined study oversight.
-
Everest Group Life Sciences eCOA Peak Matrix Assessment 20259/16/2025
Discover how digital platforms are revolutionizing clinical trials by improving data quality and patient engagement in this comprehensive market assessment.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![GettyImages-2174865907 workflow, lab, cell therapy]( "High-Content Flow Cytometry")
Flow cytometry is a foundational tool in modern drug development, and its application in receptor occupancy assays has become essential for evaluating therapeutic engagement with disease targets.
-
![GettyImages-1390000434 patients]( "Revolutionizing Engagement, Education, & Enrollment Across Clinical Portfolios")
Discover ways to amplify dialogue, trust, and participation around your clinical trials with Citeline’s end-to-end enterprise patient engagement and recruitment solution.
-
![Rare Disease Clinical Trials – The Importance Of Rigorous Study Designs]( "Get Novel Infectious Disease Vaccines, Therapies To Market Faster")
Infectious diseases are a threat to global health and way of life everywhere. Time is of the essence when it comes to developing safe and effective infectious disease vaccines and treatments.
-
![Asia iStock-1190455899]( "The Asia Drug Development Advantage")
Avance Clinical has located its Asia hub operations in Seoul, South Korea which is highly regarded for its advanced technology and scientific and medical excellence.
-
![Medicine-pills-tablets-GettyImages-545993684]( "Human Abuse Potential")
With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.
